Top Section/Ad
Top Section/Ad
Most recent
◆ Praemia refis at a tighter coupon ◆ Schneider lands tight at the short end ◆ Minimal concessions needed
French biotech seeks to accelerate cancer vaccine program
◆ Single digit premiums offered ◆ Reverse Yankees dominating euro supply ◆ Floaters proving popular with multi-tranche issuers
Pair enjoyed strong execution and tight pricing as US high grade credit remained resilient in the face of a sell-off in equity markets
More articles/Ad
More articles/Ad
More articles
-
Europe's biggest IPO of the year so far gains traction with investors -
After the listings in February delivered, Galderma adds fuel to the European IPO recovery
-
Long delayed listing of Nestlé's former skincare division is finally underway
-
LivaNova and MicroStrategy ride US tech convertible wave as maturity wall pushes issuers to refinance
-
Bankers hopeful more supply will follow, but no pipeline forthcoming
-
The strong market conditions are tempting cash rich issuers
